Higher serum levels of IL-16 were observed in patients with obesity compared with normal-weight individuals, with an increase 6 months after bariatric surgery that is reverted 12 months after the intervention (Supplementary Figure S1). Here, IL16 is linked to obesity due to melanocortin 4 receptor deficiency.